Monday, 31 August 2026European Markets

FORSEE POWER Stock Is 9% Up So Far On Thursday

Loading stream...

(vianews) - shares of forsee power (cac 40: forse.pa) rose 9.5% to €3.29 at 11:52 est on thursday, after five sequential sessions in a row of losses. cac 40 is jumping 0.4% to €7,496.44, after three sequential sessions in a row of losses. this seems, so far, a somewhat up trend exchanging session today.

about forsee power

forsee power société anonyme, together with its subsidiaries, engages in the design, manufacture, assemble, and supply of lithium-based battery systems for mobility applications in france, rest of europe, asia, the united states, and internationally. it operates in two segments: heavy vehicles, and light vehicles and industrial tech. the company's products are used in the field of autonomy and mobility for applications in bicycles, scooters, rolling stock, medical facilities, home automation, professional tools, etc.; electric transport for applications in buses, trucks, trams, shipping and rail transport, and marine and offshore vessels; and storage of electrical energy for residential, commercial, and industrial market applications. forsee power sas was incorporated in 2007 and is headquartered in ivry-sur-seine, france.

earnings per share

as for profitability, forsee power has a trailing twelve months eps of €-0.56.

volume

today's last reported volume for forsee power is 26806 which is 15.17% above its average volume of 23274.

more news about forsee power (forse.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com